Implications of immune cells in oncolytic herpes simplex virotherapy for glioma
Yoshihiro Otani(Okayama University), Balveen Kaur(Augusta University), Isao Date(Okayama University Hospital), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Kazuhiko Kurozumi(Okayama University), Toshihiko Shimizu(The University of Texas Health Science Center)
Cited by 21
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332
VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth
|Molecular Therapy|2007|150
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
|Molecular Therapy|2017|147